Most recently, it's been identified that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent places as classical opioid receptors, it binds to some big range of endogenous opioids. Contrary to most opioid receptors, this receptor acts being a scavenger and isn't going to activate a next